BIOPHARMA: Biopharmaceutical Products in the U.S. and European Markets, 12th edition
BIOPHARMA®: Biopharmaceutical Products in the U.S. and European Markets
The only information resource/reference (Web database) specializing in biopharmaceutical products!
Encyclopedic monographs concentrate on products' biotechnology and commercial aspects (the hard-to-find information)
Includes all biopharmaceuticals - recombinant and other proteins, monoclonal antibodies, vaccines, enzymes, blood products,
radioimmune conjugates, cultured cells/tissues; all US/EU-approved reference, biosimilar, biobetter and biogeneric products
Besides detailed descriptions and indexing, includes much unique competitive, technological, marketing
regulatory intelligence available nowhere else (making BIOPHARMA invaluable)
Full-text Web database subscriptions available for individuals (by password) and organizations (by I.P. nos.)
New! Database Upgrade:
BIOPHARMA has become "The Reference Products Reference"
with the addition of a
Biosimilars/Biobetters Search Module
(with projected US and EU patent and market and data exclusivities expiration and product launchability dates)
The Bottom line -- If you have an interest in biopharmaceuticals, whether innovative or biosimilars/biobetters/biogenerics, the BIOPHARMA Web database is an
essential must-have information resource!BIOPHARMA is the first place to look for biopharmaceutical-related information, serving as the basic common denominator (what your competitors have access to, but you don't) information resource/reference for this industry.
The database provides much high value, even invaluable, information, including much retrievable nowhere else; has excellent
reviews; and is a bargain by pharmaceutical information standards and compared to alternatives
(either doing without or spending much more time and/or money just to retrieve bits and pieces of information about these
products and companies). BIOPHARMA provides you with the fruits of well over 3.5 man-years of
effort by world-class a biotech/pharmaceutical information specialist.
Authored by a single individual and now in its 12th year, BIOPHARMA
provides a level of consistency in coverage, presentation, indexing, etc. not found in most other pharmaceutical/biotech information
resources. But with the database being a massive work, >1.3 million words, likely >2,600 dense pages if printed,
with over 670 product monographs, authorship by an individual also has its limitations. For example, preexisting monographs
are now generally updated with new information added rather than being fully rewritten/updated (so tenses can be off, e.g.,
"will" used vs. now proper use of "is" or "was").